Emmy M. Dolman

Utrecht, UT 3584CS, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Precision-guided therapy in H3K27-altered diffuse midline glioma.

Precision-guided therapy in H3K27-altered diffuse midline glioma.

Journal: Nature communications

Published: May 30, 2025

Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy.

Modeling High-Risk Pediatric Cancers in Zebrafish to Inform Precision Therapy.

Journal: Cancer research communications

Published: February 07, 2025

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine.

Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 15, 2023

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.

RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition.

Journal: Science advances

Published: July 20, 2022

Neuroblastoma and DIPG Organoid Coculture System for Personalized Assessment of Novel Anticancer Immunotherapies.

Neuroblastoma and DIPG Organoid Coculture System for Personalized Assessment of Novel Anticancer Immunotherapies.

Journal: Journal of personalized medicine

Published: August 19, 2021

Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.

Accelerating drug development for neuroblastoma: Summary of the Second Neuroblastoma Drug Development Strategy forum from Innovative Therapies for Children with Cancer and International Society of Paediatric Oncology Europe Neuroblastoma.

Journal: European journal of cancer (Oxford, England : 1990)

Published: January 09, 2020

An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.

An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.

Journal: Nature communications

Published: January 10, 2019

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.

TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.

Journal: Nature communications

Published: March 07, 2018

Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells.

Anti-GD2 Immunoliposomes for Targeted Delivery of the Survivin Inhibitor Sepantronium Bromide (YM155) to Neuroblastoma Tumor Cells.

Journal: Pharmaceutical research

Published: November 09, 2017

ALK positively regulates MYCN activity through repression of HBP1 expression.

ALK positively regulates MYCN activity through repression of HBP1 expression.

Journal: Oncogene

Published: October 16, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026